Company The Medicines Company

MDCO

US5846881051

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Generic Pharmaceuticals

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.14%	-0.05%

2020	The Medicines Company Announces Board Changes	CI
2020	The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care	CI

The Medicines Company is a global biopharmaceutical company. The Company is focused on the development of inclisiran, a twice-yearly therapy that allows administration during patients routine visits to their healthcare professionals and potentially contributes to improved patient adherence and sustained lower LDL-C levels. The Company is a subsidiary of Novartis AG.

Managers	Title	Age	Since
Krishna Gorti IRC	Investor Relations Contact	-	-
Stephen M. Rodin LAW	General Counsel	47	-

Members of the board	Title	Age	Since
John C. Kelly BRD	Director/Board Member	81	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	82,946,319	77,112,694 ( 92.97 %)	3,013,143 ( 3.633 %)	92.97 %

The Medicines Co.

8 Sylvan Way

07054-3801, Parsippany

+973-290-6000

http://www.themedicinescompany.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals

	1st Jan change	Capi.
THE MEDICINES COMPANY	-0.05%	6.79B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-4.29%	4.71B

Generic Pharmaceuticals